Borrelia recurrentis infection: single-dose antibiotic regimens and management of the Jarisch-Herxheimer reaction.
D000082:Acetaminophen / Q000627:therapeutic use; D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000009:adverse effects; D004342:Drug Hypersensitivity / Q000517:prevention & control; D004917:Erythromycin / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D010400:Penicillin G / Q000008:administration & dosage / Q000009:adverse effects; D012061:Relapsing Fever / Q000188:drug therapy*; D013577:Syndrome; D013752:Tetracycline / Q000008:administration & dosage / Q000009:adverse effects
D000900:Anti-Bacterial Agents; D000082:Acetaminophen; D004917:Erythromycin; D013752:Tetracycline; D010400:Penicillin G; D006854:Hydrocortisone